Brendan McMullan profile

Brendan McMullan

Publication | June, 2022
Phage Therapy

Phage Therapy of Mycobacterium Infections: Compassionate-use of Phages in Twenty Patients with Drug-Resistant Mycobacterial Disease

Clinical Infectious Diseases
Authors: Rebekah M. Dedrick, Bailey E. Smith, Madison Cristinziano, Krista G. Freeman, Deborah Jacobs-Sera, Yvonne Belessis, A. Whitney Brown, Keira A. Cohen, Rebecca M. Davidson, David van Duin, Andrew Gainey, Cristina Berastegui Garcia, C.R. Robert George, Ghady Haidar, Winnie Ip, Jonathan Iredell, Ameneh Khatami, Jessica S. Little, Kirsi Malmivaara, Brendan J. McMullan, David E. Michalik, Andrea Moscatelli, Jerry A. Nick, Maria G. Tupayachi Ortiz, Hari M. Polenakovik, Paul D. Robinson, Mikael Skurnik, Daniel A. Solomon, James Soothill, Helen Spencer, Peter Wark, Austen Worth, Robert T. Schooley, Constance A. Benson, Graham F. Hatfull
Phage Australia logo

Phage Australia is a national network of phage researchers and clinician scientists who aim to professionalise phage therapy as the third major intervention for infectious diseases, after vaccines and antibiotics.

We acknowledge the traditional custodians of the First Nation, whose culture and customs have nurtured and continue to nurture this land, since the Dreamtime. We pay our respects to Elders past, present and emerging and celebrate the diversity of Aboriginal peoples and their ongoing cultures and connections to the lands and waters of Australia

Resources
Sequence your phages
Request phage therapy
Media / Press Kit
Glossary
Grant Appendix
info@phageaustralia.org @phageaustralia Linkedin
© 2024 Phage Australia